This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Santolecan Pharmaceuticals LLC. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Ang Zha: Innovator in Drug Delivery Systems
Introduction
Ang Zha is a prominent inventor based in Guangzhou, China. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of innovative drug delivery systems. His work focuses on enhancing the efficacy of drug formulations through novel conjugates.
Latest Patents
Ang Zha holds a patent for "Taxane-lipid-polysaccharide dual conjugates, preparation methods thereof and uses thereof." This invention pertains to a group of taxane-lipid-polysaccharide dual conjugates, which are designed to improve drug delivery. The patent outlines a process for the preparation of these conjugates and their applications in pharmaceutical compositions. The invention also includes a series of intermediates for the preparation of these dual conjugates, emphasizing their potential as effective drug delivery vehicles. He has 1 patent to his name.
Career Highlights
Ang Zha is currently associated with Santolecan Pharmaceuticals LLC, where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to advancing drug delivery technologies that can significantly impact patient care.
Collaborations
Ang Zha collaborates with notable colleagues, including Jinghua Hu and Xiaohai Li, who contribute to his research and development efforts.
Conclusion
Ang Zha's innovative work in drug delivery systems exemplifies the importance of research and development in pharmaceuticals. His contributions are paving the way for more effective treatments and improved patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile